Investigating new treatments for breast cancer, especially triple-negative types.
SPORE in Breast Cancer
This study is all about finding better ways to treat breast cancer, especially for those with triple-negative breast cancer, by using new ideas and tests to personalize treatments based on what works best for each patient.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11192999 on NIH RePORTER |
What this research studies
This research focuses on improving outcomes for patients with breast cancer, particularly those with triple-negative breast cancer (TNBC). It involves collaborative efforts among experts to explore innovative strategies, including genomic and immune-based discoveries, to enhance treatment responses. The research also aims to utilize liquid biopsies to tailor therapies for TNBC patients, ensuring that patient perspectives are integrated throughout the process. By leveraging advanced biostatistics and bioinformatics, the study seeks to provide meaningful insights into breast cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with triple-negative breast cancer or those at high risk for developing breast cancer.
Not a fit: Patients with non-breast cancer conditions or those not diagnosed with breast cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for breast cancer patients.
How similar studies have performed: Previous research has shown promise in similar approaches targeting breast cancer, particularly in enhancing immunotherapy responses.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Pietenpol, Jennifer a — Vanderbilt University Medical Center
- Study coordinator: Pietenpol, Jennifer a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.